Etiological and non-etiological therapies for cirrhotic portal hypertension / 临床肝胆病杂志
Journal of Clinical Hepatology
;
(12): 1224-1228, 2022.
Article
in Chinese
| WPRIM
| ID: wpr-924688
ABSTRACT
Portal hypertension is a serious complication of liver cirrhosis resulting from the increases in portal vascular resistance and portal blood inflow. Both etiological and non-etiological therapies can effectively reduce portal venous pressure to a certain degree, but with an unsatisfactory effect in improving prognosis. New therapeutic drugs targeting the reduction in intrahepatic vascular resistance may help to achieve the reversal of portal hypertension. Based on the pathogenesis of cirrhotic portal hypertension, this article summarizes the current pharmacotherapies from the aspects of etiological and non-etiological therapies, so as to provide a comprehensive theoretical and evidence-based basis for clinical treatment options.
Full text:
Available
Index:
WPRIM (Western Pacific)
Type of study:
Etiology study
Language:
Chinese
Journal:
Journal of Clinical Hepatology
Year:
2022
Type:
Article
Similar
MEDLINE
...
LILACS
LIS